Richard A. Edlin

Insider Reports History

Entity
Individual
Location
C/O Eagle Pharmaceuticals, Inc., 50 Tice Boulevard, Suite 315, Woodcliff Lake, NJ
Signature
/s/ Scott Tarriff, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Richard A. Edlin:

Stock Role Class Num Shares Value Price $ Report Date Ownership
EAGLE PHARMACEUTICALS, INC. Director Common Stock 22.6K $116K $5.13 Sep 6, 2022 Direct
EAGLE PHARMACEUTICALS, INC. Director Stock Option (right to buy) 16.3K Mar 7, 2023 Direct

Insider Reports Filed by Richard A. Edlin

Symbol Company Period Transactions Value $ Form Type Date Filed Role
EGRX EAGLE PHARMACEUTICALS, INC. Mar 7, 2023 1 $0 4 Mar 9, 2023 Director
EGRX EAGLE PHARMACEUTICALS, INC. Sep 6, 2022 1 -$211K 4 Sep 8, 2022 Director
EGRX EAGLE PHARMACEUTICALS, INC. Feb 28, 2022 1 $0 4 Mar 2, 2022 Director